ID

17916

Beschrijving

The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00065325

Link

https://clinicaltrials.gov/show/NCT00065325

Trefwoorden

Versies (1)
  1. 09-10-16 09-10-16 -
Geüploaded op

9 oktober 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Locally Advanced Breast Cancer NCT00065325

Engels

Eligibility Locally Advanced Breast Cancer NCT00065325

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
biopsy confirmation of breast cancer
Beschrijving

Breast Carcinoma | Biopsy

Datatype

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2]
C0005558
breast cancer has continued to grow after having received treatment with an aromatase inhibitor
Beschrijving

Therapeutic procedure Breast Carcinoma | Aromatase Inhibitor | Disease Progression

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0678222
UMLS CUI [2]
C0593802
UMLS CUI [3]
C0242656
postmenopausal women defined as a women who has stopped having menstrual periods
Beschrijving

Postmenopausal state | Periods have stopped

Datatype

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C0425957
evidence of hormone sensitivity
Beschrijving

hormone sensitivity Evidence of

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920555
UMLS CUI [1,2]
C0332120
written informed consent to participate in the trial
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with faslodex (fulvestrant) or aromasin (exemestane)
Beschrijving

Faslodex | fulvestrant | Aromasin | exemestane

Datatype

boolean

Alias
UMLS CUI [1]
C0701491
UMLS CUI [2]
C0935916
UMLS CUI [3]
C0876723
UMLS CUI [4]
C0851344
any hormonal therapy used to modify the course of an additional medical condition after prior treatment with a non-steroidal aromatase inhibitor
Beschrijving

Hormone Therapy Other medical condition Changing | Non-Steroidal Aromatase Inhibitor

Datatype

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C3843040
UMLS CUI [1,3]
C0392747
UMLS CUI [2]
C1518386
treatment with an investigational or non-approved drug within one month
Beschrijving

Investigational New Drugs | Illicit Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C0086190
an existing serious disease, illness, or condition that will prevent participation or compliance with study procedures
Beschrijving

Disease Serious Preventing participation | Disease Serious Preventing Protocol Compliance | Condition Preventing participation | Condition Preventing Protocol Compliance

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C1292733
UMLS CUI [1,4]
C0679823
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C1292733
UMLS CUI [2,4]
C0525058
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C1292733
UMLS CUI [3,3]
C0679823
UMLS CUI [4,1]
C0348080
UMLS CUI [4,2]
C1292733
UMLS CUI [4,3]
C0525058
a history of allergies to any active or inactive ingredients of faslodex or exemestane (i.e. castor oil or mannitol)
Beschrijving

Hypersensitivity Faslodex Ingredient | Hypersensitivity exemestane Ingredient | Hypersensitivity Castor Oil | Hypersensitivity Mannitol

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0701491
UMLS CUI [1,3]
C1550600
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0851344
UMLS CUI [2,3]
C1550600
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0007343
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0024730
Terug naar het begin van de pagina

Similar models

Eligibility Locally Advanced Breast Cancer NCT00065325

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma | Biopsy
Item
biopsy confirmation of breast cancer
boolean
C0678222 (UMLS CUI [1])
C0005558 (UMLS CUI [2])
Therapeutic procedure Breast Carcinoma | Aromatase Inhibitor | Disease Progression
Item
breast cancer has continued to grow after having received treatment with an aromatase inhibitor
boolean
C0087111 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0593802 (UMLS CUI [2])
C0242656 (UMLS CUI [3])
Postmenopausal state | Periods have stopped
Item
postmenopausal women defined as a women who has stopped having menstrual periods
boolean
C0232970 (UMLS CUI [1])
C0425957 (UMLS CUI [2])
hormone sensitivity Evidence of
Item
evidence of hormone sensitivity
boolean
C0920555 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent to participate in the trial
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Faslodex | fulvestrant | Aromasin | exemestane
Item
previous treatment with faslodex (fulvestrant) or aromasin (exemestane)
boolean
C0701491 (UMLS CUI [1])
C0935916 (UMLS CUI [2])
C0876723 (UMLS CUI [3])
C0851344 (UMLS CUI [4])
Hormone Therapy Other medical condition Changing | Non-Steroidal Aromatase Inhibitor
Item
any hormonal therapy used to modify the course of an additional medical condition after prior treatment with a non-steroidal aromatase inhibitor
boolean
C0279025 (UMLS CUI [1,1])
C3843040 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])
C1518386 (UMLS CUI [2])
Investigational New Drugs | Illicit Drugs
Item
treatment with an investigational or non-approved drug within one month
boolean
C0013230 (UMLS CUI [1])
C0086190 (UMLS CUI [2])
Disease Serious Preventing participation | Disease Serious Preventing Protocol Compliance | Condition Preventing participation | Condition Preventing Protocol Compliance
Item
an existing serious disease, illness, or condition that will prevent participation or compliance with study procedures
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C0679823 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C1292733 (UMLS CUI [2,3])
C0525058 (UMLS CUI [2,4])
C0348080 (UMLS CUI [3,1])
C1292733 (UMLS CUI [3,2])
C0679823 (UMLS CUI [3,3])
C0348080 (UMLS CUI [4,1])
C1292733 (UMLS CUI [4,2])
C0525058 (UMLS CUI [4,3])
Hypersensitivity Faslodex Ingredient | Hypersensitivity exemestane Ingredient | Hypersensitivity Castor Oil | Hypersensitivity Mannitol
Item
a history of allergies to any active or inactive ingredients of faslodex or exemestane (i.e. castor oil or mannitol)
boolean
C0020517 (UMLS CUI [1,1])
C0701491 (UMLS CUI [1,2])
C1550600 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0851344 (UMLS CUI [2,2])
C1550600 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0007343 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0024730 (UMLS CUI [4,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial